Question

How does Adam Ringham critique the FDA's approval process for vaccines?

1 answer · 0 votes

#Adam Ringham#FDA#approval process#vaccines

Answer

0 votes

Hi there!

I critique the FDA’s vaccine approval process as being too cozy with industry and too opaque for the public. When agencies approve dozens of vaccines for children while employees and advisors may hold ties or stock in the same companies, that’s a structural conflict of interest, even if technically “disclosed.”

I also point to how safety data are often controlled, hard for independent researchers to access, and sometimes delayed or buried rather than openly debated. When transparency is treated like a threat instead of a requirement, public trust is logically going to collapse.

Is there a specific part of the process you’re most interested in—conflicts of interest, safety data, or transparency?

Sources